VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,620 | -27.6% | 24,131 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -50.0% | 24,131 | -4.5% | 0.00% | – |
| Q2 2022 | $10,000 | -37.5% | 25,264 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $16,000 | -38.5% | 25,264 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $26,000 | -25.7% | 25,264 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | -60.7% | 25,264 | 0.0% | 0.00% | -75.0% |
| Q2 2021 | $89,000 | -48.6% | 25,264 | 0.0% | 0.00% | -42.9% |
| Q1 2021 | $173,000 | – | 25,264 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 2,551,000 | $2,602,000 | 2.01% |
| Perceptive Advisors | 4,356,044 | $4,444,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 217,747 | $222,000 | 0.03% |
| Virtu Financial LLC | 175,278 | $179,000 | 0.02% |
| XTX Topco Ltd | 17,053 | $17,000 | 0.01% |
| SkyOak Wealth, LLC | 27,200 | $28,000 | 0.01% |
| DELTEC ASSET MANAGEMENT LLC | 30,000 | $31,000 | 0.01% |
| Tekla Capital Management LLC | 135,395 | $138,000 | 0.00% |
| STALEY CAPITAL ADVISERS INC | 62,500 | $64,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 47,475 | $48,000 | 0.00% |